TherageniX is looking for a Scientific Project Manager
Job Title Scientific Project Manager Job Type Fixed-Term 1 year (with possibility of extension), Full-time Hours per week 37.5 per week Location Remote with occasional travel within the UK Pay £45,000 – £50,000 per annum plus benefits Start Date January 2024 About Us TherageniX is an early-stage biotechnology company focused on using a gene therapy […]
TherageniX and University of Nottingham Awarded £995K Innovate UK Grant to Develop Powdered Gene Therapy for Bone Regeneration
London, UK, and Nottingham, UK, 31 August 2023: TherageniX, a University of Nottingham spin out pioneering a dry powder gene therapy formulation for bone graft augmentation, and its collaborator, the University of Nottingham, have been awarded a £995,000 grant from Innovate UK, the UK’s innovation agency. The funding will support the development of the Company’s […]
THERAGENIX: SPIN-OUT COMPANY ESTABLISHED TO PROVIDE GENE THERAPY IN BONE REPAIR SURGERY
Our partner, U of N also shared their perspective on the launch of TherageniX, a spin-out company – TherageniX to deliver gene therapy as part of bone repair surgery. The innovative approach aims to enhance the healing process by introducing genes that promote bone regeneration. TherageniX establishment signifies a significant step towards translating research findings into practical applications, […]
INTRODUCING THERAGENIX: TISSUE REGENERATION THROUGH GENES
Disease, injuries and aging can damage body tissues. There is an unmet need for novel therapies to enable tissue repair and regeneration. The use of gene therapy to provide biological cues to boost the body’s response has been shown to aid regeneration of skin, bone, muscle and cartilage. TherageniX, another venture from NLC, delivers genes […]